NRIX
Nurix Therapeutics, Inc.
+0.48 (+1.91%)25.63USD516K成交股數2.7B市值–本益比(近四季)72.3股價營收比-79.5%營收年增(近四季)2026-10-08下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 11 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 9.0M-51% | 6.3M-53% | 7.9M-37% | 44.1M+264% | 18.5M+11% | 13.3M-28% | 12.6M-59% | 12.1M-5% | 16.6M | 18.5M | 30.7M | 12.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 87.7M | 84.1M | 86.1M | 78.1M | 69.7M | 67.2M | 55.5M | 48.9M | 50.0M | 47.9M | 45.8M | 45.8M |
| 銷售管理費用 | 15.6M | 14.6M | 13.2M | 14.3M | 11.7M | 10.7M | 11.7M | 11.7M | 11.8M | 10.6M | 11.7M | 9.8M |
| 營業利益 | −94.2M+50% | −92.5M+43% | −91.4M+67% | −48.3M-0% | −62.9M+39% | −64.7M+62% | −54.6M+104% | −48.5M+13% | −45.2M | −40.0M | −26.8M | −43.0M |
| 營業利益率 | -1,041.7% | -1,479.4% | -1,157.7% | -109.7% | -340.7% | -486.7% | -433.8% | -401.4% | -272.6% | -216.7% | -87.3% | -338.6% |
| 稅後淨利 | −89.5M+59% | −87.2M+49% | −86.4M+77% | −43.5M-2% | −56.4M+36% | −58.5M+58% | −49.0M+102% | −44.5M+9% | −41.5M | −37.0M | −24.3M | −40.7M |
| 淨利率 | -990.1% | -1,394.3% | -1,094.8% | -98.7% | -305.4% | -440.7% | -388.9% | -368.4% | -250.3% | -200.3% | -79.1% | -321.1% |
| 稀釋 EPS | -0.81+21% | -0.79+7% | -1.03+54% | -0.52-27% | -0.67-12% | -0.74+9% | -0.67+49% | -0.71-5% | -0.76 | -0.68 | -0.45 | -0.75 |
| 稀釋股數 | 111M | 110M | 84.2M | 83.9M | 83.6M | 67.1M | 72.8M | 62.4M | 54.9M | 54.4M | 54.3M | 54.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 67.7M | 71.2M | 78.4M | 84.3M | 75.9M | 110M | 99.0M | 117M | 49.8M | 42.3M | 59.0M | 33.6M |
| 應收帳款 | – | – | – | 19.0M | – | 0.00 | – | – | – | 2.0M | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 536M | 636M | 522M | 592M | 615M | 669M | 514M | 511M | 313M | 308M | 351M | 370M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 133M | 155M | 150M | 144M | 134M | 142M | 137M | 140M | 144M | 74.4M | 90.7M | 96.1M |
| 股東權益 | 403M | 481M | 372M | 448M | 481M | 527M | 377M | 371M | 169M | 234M | 260M | 274M |
| 負債比 | 24.8% | 24.4% | 28.8% | 24.3% | 21.8% | 21.3% | 26.6% | 27.5% | 46.0% | 24.1% | 25.9% | 26.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −71.9M | – | – | −61.1M+46% | – | – | – | −42.0M | – | – | −48.5M |
| 資本支出 | – | 1.0M | – | – | 3.5M | – | – | – | 2.9M | – | – | 2.3M |
| 自由現金流 | – | −73.0M | – | – | −64.6M+44% | – | – | – | −44.8M | – | – | −50.7M |
| 折舊攤銷 | – | 2.2M | – | – | 2.4M | – | – | – | 2.0M | – | – | 1.8M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1,167.0% | – | – | -349.9% | – | – | – | -270.3% | – | – | -399.9% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 84.0M
| Collaboration Revenue | 54.0M | 64.3% | -1.0% |
|---|---|---|---|
| License Revenue | 30.0M | 35.7% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 84.0M | +54.0% | −264M | -314.9% | -3.05 | −263M |
| FY2024 | 54.5M | -29.1% | −194M | -354.9% | -2.88 | −182M |
| FY2023 | 77.0M | +99.3% | −144M | -187.0% | -2.65 | −89.8M |
| FY2022 | 38.6M | +29.8% | −180M | -466.9% | -3.71 | −172M |
| FY2021 | 29.8M | +66.9% | −117M | -393.9% | -2.73 | −90.0M |
| FY2020 | 17.8M | -42.7% | −43.2M | -242.7% | -2.76 | −4.6M |
| FY2019 | 31.1M | – | −21.7M | -69.7% | -6.59 | −1.1M |